Asthma: diagnosis, monitoring and chronic asthma management- updated guideline (NG80)

NICE has reviewed evidence on increasing dose of inhaled corticosteroids within a self-management programme in children and young people with asthma and removed a recommendation, as well as making new recommendations on self-management in this age group.

SPS commentary:

The guidance has been revised to recommend that for children and young people aged 5 to 16 with a diagnosis of asthma, include advice in their self-management programme on contacting a healthcare professional for a review if their asthma control deteriorates. Those patients with deteriorating asthma who have not been taking their inhaled corticosteroid (ICS) consistently, should be advised that restarting regular use may help them to regain control of their asthma. It was noted that the evidence for increasing ICS doses to self-manage deteriorating asthma control is limited.


National Institute for Health and Care Excellence